Expand VTGN Menu
VTGN MENU

VTGN Stock Posts


Upcoming Earnings

VTGN Vistagen Therapeutics0.56-0.01 (-2.1%)

Vistagen Therapeutics will report earnings after the market closes. View Calendar The market is expecting a ±10.1% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±6.6%. View Expected Move (Conf Call: Feb 12 5:00 PM)
Unusual Option Volume

VTGN Vistagen Therapeutics0.68-0.05 (-6.6%)

Vistagen Therapeutics trades 5,906 contracts.
Unusual Option Volume

VTGN Vistagen Therapeutics0.70-0.03 (-3.9%)

Vistagen Therapeutics trades 2,798 contracts. The highest volume is in the 16-Jan-26 3 puts, which is -328.6% below the current price.
Unusual Option Volume

VTGN Vistagen Therapeutics0.740.00 (0.0%)

Vistagen Therapeutics trades 1,198 contracts.
Unusual Option Volume

VTGN Vistagen Therapeutics0.83-0.03 (-3.6%)

Vistagen Therapeutics trades 1,267 contracts.
Unusual Option Volume

VTGN Vistagen Therapeutics0.88-3.48 (-79.8%)

Vistagen Therapeutics trades 3,480 contracts. The company has the following event: Topline Results from PALISADE-3 Phase 3 Public Speaking Challenge Study of Fasedienol on Dec 17, 2025. News: Vistagen Announces Topline Results from PALISADE-3 Phase 3 Public Speaking Challenge Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
Market Data Delayed 15 Minutes